Home » MIV THERAPEUTICS' PASSIVE STENT COATINGS ACCEPTED FOR PRESENTATION AT PRESTIGIOUS WORLD CONFERENCE ON CARDIOVASCULAR THERAPY
MIV THERAPEUTICS' PASSIVE STENT COATINGS ACCEPTED FOR PRESENTATION AT PRESTIGIOUS WORLD CONFERENCE ON CARDIOVASCULAR THERAPY
MIV Therapeutics, Inc., a developer of next-generation biocompatible stent coatings and drug delivery technologies for the treatment of cardiovascular disease, announced that interim results of a long-term animal study of its proprietary ultra-thin Hydroxyapatite coating will be featured at this year's 17th annual Transcatheter Cardiovascular Therapeutics (TCT) 2005 conference in Washington, D.C.
Yahoo Finance (http://biz.yahoo.com/bw/050912/125326.html?.v=1)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May